Dose-response modeling of 3-nitrobenzanthrone-induced alterations of the energy metabolism in urothelial cells
3-硝基苯并蒽酮诱导尿路上皮细胞能量代谢改变的剂量反应模型
基本信息
- 批准号:319975898
- 负责人:
- 金额:--
- 依托单位:
- 依托单位国家:德国
- 项目类别:Research Grants
- 财政年份:2016
- 资助国家:德国
- 起止时间:2015-12-31 至 2018-12-31
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
Bladder cancer is one of the most prevalent cancers and is often linked with exposure to certain chemicals. Besides the known carcinogens such as 2-naphthylamine, polycyclic aromatic hydrocarbons are increasingly discussed as risk factors. In addition, a positive association has been observed between exposure to diesel engine exhaust and cancer of the urinary bladder. A powerful mutagenic and clastogenic compound of diesel exhaust is the nitrated polycyclic aromatic hydrocarbon 3-nitrobenzanthrone (3-NBA). 3-NBA is reduced to reactive intermediates and produced the highest score ever reported in the Ames-test. It is carcinogenic in rats causing lung tumors and was classified as possible carcinogenic to humans by the IARC.Adducts and an increased mutant frequency were detected in various organs as lung, kidney and bladder. The main metabolite of 3-NBA, 3-aminobenzanthrone (3-ABA), was found in the urine of salt mine workers occupationally exposed to diesel emissions. It can therefore be assumed that the bladder is also a target organ of toxicity. As most studies have so far only partially investigated the underlying mechanism predominant in lung cells, the proposed project will highlight the cellular response to 3-NBA in urothelial cells. Recently, cancer biology has recalled Otto Warburgs description of the switch to glycolysis in cancer cells (1956) and started to elucidate the metabolic reprogramming in cancer. While the importance of metabolism in cancer is becoming increasingly apparent, our comprehension of the metabolic response to xenobiotic exposure lags behind other areas of toxicological research. The energy metabolism plays a fundamental role in the anti-oxidant defense and DNA repair by activating pathways such as the pentose phosphate pathway. From a toxicological point of view the threshold above which the cell cannot successfully manage the maintenance of the homeostasis by the switch in energy metabolism would be of particular interest. This threshold may serve as a point where cell transition from stress adaptation to stress-related adversity takes place. Therefore, in the proposed project, the dose response relationship in the energy metabolism with regard to anti-oxidative defense and DNA repair will be investigated. In addition, the changes will be linked to posttranslational modifications of p53 which is being reported to regulate central aspects of energy metabolism, anti-oxidant defense and DNA repair. Finally, the underlying biochemical control network pathways will be mathematically modelled with the objective of simulating the dose response curve in the low-dose region. This approach might allow examining the issue of threshold response.
膀胱癌是最常见的癌症之一,通常与暴露于某些化学物质有关。除了已知的致癌物如2-萘胺,多环芳烃越来越多地被讨论为风险因素。此外,还观察到柴油机废气与膀胱癌之间存在正相关。柴油机尾气中的硝化多环芳烃3-硝基苯并蒽酮(3-NBA)是一种强致突变和致染色体断裂的化合物。3-NBA被还原为活性中间体,并在Ames测试中获得了有史以来最高的分数。它对大鼠具有致癌性,可导致肺部肿瘤,并被国际癌症研究机构归类为可能对人类致癌。在肺、肾脏和膀胱等多个器官中检测到加合物和突变频率增加。3-氨基苯并蒽酮(3-阿坝)是3-NBA的主要代谢产物。因此,可以假设膀胱也是毒性的靶器官。由于迄今为止大多数研究仅部分研究了肺细胞中占主导地位的潜在机制,因此拟议的项目将突出尿路上皮细胞对3-NBA的细胞反应。最近,癌症生物学回顾了Otto Warburgs对癌细胞中糖酵解转换的描述(1956),并开始阐明癌症中的代谢重编程。虽然代谢在癌症中的重要性越来越明显,但我们对外源性物质暴露的代谢反应的理解落后于毒理学研究的其他领域。能量代谢通过激活戊糖磷酸途径等途径在抗氧化防御和DNA修复中起着重要作用。从毒理学的角度来看,细胞不能成功地通过能量代谢的转换来维持稳态的阈值将是特别感兴趣的。这个阈值可以作为细胞从压力适应到压力相关逆境的过渡点。因此,在拟议的项目中,将研究能量代谢中与抗氧化防御和DNA修复有关的剂量反应关系。此外,这些变化将与p53的翻译后修饰有关,据报道p53可以调节能量代谢、抗氧化防御和DNA修复的核心方面。最后,将对潜在的生化控制网络途径进行数学建模,目的是模拟低剂量区的剂量反应曲线。这一办法可能有助于审查最低限度反应问题。
项目成果
期刊论文数量(3)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
753 Combination of cellular assays with metabolomics revealed mechanistic insights on dose-response relationship of 3-nitrobenzanthrone in human urothelial cancer cells
753â结合细胞测定与代谢组学揭示了人类尿路上皮癌细胞中 3-硝基苯并蒽酮剂量反应关系的机制见解
- DOI:10.1136/oemed-2018-icohabstracts.1181
- 发表时间:2018
- 期刊:
- 影响因子:4.9
- 作者:Schmitz-Spanke;N. Verma;A. Zerries;M. Pink
- 通讯作者:M. Pink
Dose-Dependent Response to 3-Nitrobenzanthrone Exposure in Human Urothelial Cancer Cells.
人尿路上皮癌细胞对 3-硝基苯并蒽酮暴露的剂量依赖性反应
- DOI:10.1021/acs.chemrestox.7b00174
- 发表时间:2017
- 期刊:
- 影响因子:4.1
- 作者:N. Verma;A. Zerries;S. Schmitz-Spanke
- 通讯作者:S. Schmitz-Spanke
ROS and pentose phosphate pathway: mathematical modelling of the metabolic regulation in response to xenobiotic-induced oxidative stress and the proposed Impact of the gluconate shunt
ROS和磷酸戊糖途径:响应外源性诱导的氧化应激的代谢调节的数学模型以及葡萄糖酸分流的拟议影响
- DOI:10.1080/10715762.2019.1660777
- 发表时间:2019
- 期刊:
- 影响因子:3.3
- 作者:Schittenhelm;M. Neuss-Radu;N. Verma;M. Pink;S. Schmitz-Spanke
- 通讯作者:S. Schmitz-Spanke
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Professorin Dr. Simone Schmitz-Spanke其他文献
Professorin Dr. Simone Schmitz-Spanke的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
相似国自然基金
RIPK3蛋白及其RHIM结构域在脓毒症早期炎症反应和脏器损伤中的作用和机制研究
- 批准号:82372167
- 批准年份:2023
- 资助金额:48.00 万元
- 项目类别:面上项目
YTHDF1通过m6A修饰调控耳蜗毛细胞炎症反应在老年性聋中的作用机制研究
- 批准号:82371140
- 批准年份:2023
- 资助金额:49.00 万元
- 项目类别:面上项目
基于FCER1G基因介导免疫反应探讨迟发性聋与认知障碍相关性的机制研究
- 批准号:82371141
- 批准年份:2023
- 资助金额:49.00 万元
- 项目类别:面上项目
cGAS-STING激活IFN1反应介导噪声性耳蜗损伤机制研究
- 批准号:82371152
- 批准年份:2023
- 资助金额:49.00 万元
- 项目类别:面上项目
PKM2调控CHIP-HSP70-BAG3复合体介导的错误折叠蛋白聚集和清除的分子机制及其在肿瘤靶向治疗中的意义
- 批准号:32000533
- 批准年份:2020
- 资助金额:24.0 万元
- 项目类别:青年科学基金项目
长期内质网应激产生原朊病毒蛋白抵抗胰腺癌细胞凋亡的分子机制
- 批准号:32000535
- 批准年份:2020
- 资助金额:24.0 万元
- 项目类别:青年科学基金项目
拟南芥辅助共激活因子ADA2b与染色质相关因子ADIP1互作参与DNA损伤响应的机制研究
- 批准号:32000493
- 批准年份:2020
- 资助金额:24.0 万元
- 项目类别:青年科学基金项目
生长素响应因子(Auxin Response Factors)在拟南芥雄配子发育中的功能研究
- 批准号:31970520
- 批准年份:2019
- 资助金额:58.0 万元
- 项目类别:面上项目
组蛋白去乙酰化酶 1 调控线粒体未折叠蛋白反应的分子机制及对衰老相关疾病的应用
- 批准号:31900544
- 批准年份:2019
- 资助金额:15.0 万元
- 项目类别:青年科学基金项目
新型GhDRP1(Drought Response Protein1) 调控棉花应答干旱的分子网络解析及育种利用评价
- 批准号:31871668
- 批准年份:2018
- 资助金额:60.0 万元
- 项目类别:面上项目
相似海外基金
Low-Dose Magneto-Thrombolysis to Expand Stroke Care
低剂量磁溶栓扩大中风治疗范围
- 批准号:
10693650 - 财政年份:2023
- 资助金额:
-- - 项目类别:
Fractionated photoimmunotherapy to harness low-dose immunostimulation in ovarian cancer
分段光免疫疗法利用低剂量免疫刺激治疗卵巢癌
- 批准号:
10662778 - 财政年份:2023
- 资助金额:
-- - 项目类别:
Dose escalation clinical trial of high-dose oral montelukast to inform future RCT in children with acute asthma exacerbations
大剂量口服孟鲁司特的剂量递增临床试验为哮喘急性发作儿童的未来随机对照试验提供信息
- 批准号:
10649012 - 财政年份:2023
- 资助金额:
-- - 项目类别:
A simulation platform to predict dose and therapeutic window of immunocytokines
预测免疫细胞因子剂量和治疗窗的模拟平台
- 批准号:
10698708 - 财政年份:2023
- 资助金额:
-- - 项目类别:
Diversity Supplement: Dose-response of aerobic training during total neoadjuvant therapy for locally advanced rectal cancer
多样性补充:局部晚期直肠癌全新辅助治疗期间有氧训练的剂量反应
- 批准号:
10817969 - 财政年份:2023
- 资助金额:
-- - 项目类别:
Development of FAST-DOSE assay system for the rapid assessment of acute radiation exposure, individual radiosensitivity and injury in victims for a large-scale radiological incident
开发快速剂量测定系统,用于快速评估大规模放射事件受害者的急性辐射暴露、个体放射敏感性和损伤
- 批准号:
10784562 - 财政年份:2023
- 资助金额:
-- - 项目类别:
A single dose anti-scarring therapeutic for the cornea
单剂量角膜抗疤痕治疗剂
- 批准号:
10697582 - 财政年份:2023
- 资助金额:
-- - 项目类别:
Transcriptomic dose-response modeling to support ecological risk assessment
支持生态风险评估的转录组剂量反应模型
- 批准号:
RGPIN-2020-06571 - 财政年份:2022
- 资助金额:
-- - 项目类别:
Discovery Grants Program - Individual
Project 1: Deployable Software for the Rapid Assessment of Organ Dose Following Radionuclide Intakes
项目 1:用于快速评估放射性核素摄入后器官剂量的可部署软件
- 批准号:
10327396 - 财政年份:2022
- 资助金额:
-- - 项目类别:
Low Dose Oral Carbon Monoxide Therapeutic for Virus-Induced Lung Injury
低剂量口服一氧化碳治疗病毒引起的肺损伤
- 批准号:
10545155 - 财政年份:2022
- 资助金额:
-- - 项目类别: